Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05295498

Analgesic Effect of Accelerated Repetitive Transcranial Magnetic Stimulation in Neuropathic Pain

Led by Jakub Antczak · Updated on 2024-10-10

70

Participants Needed

1

Research Sites

203 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Peripheral neuropathy is a frequent condition, commonly associated with pain. Repetitive Transcranial Magnetic Stimulation (rTMS) is a noninvasive method of modulation of brain plasticity and is regarded as one of alternative methods to alleviate pain associated with various kind of neuropathies. rTMS is usually performed once a day and the whole therapy of neuropathic pain lasts one week. In a number of recent clinical trials including patients with depression and some other disorders, rTMS was delivered several times a day, which reduced the time of the whole therapy. This approach was termed an accelerated rTMS. The purpose of this study is to investigate feasibility of accelerated rTMS in treatment of neuropathic pain.

CONDITIONS

Official Title

Analgesic Effect of Accelerated Repetitive Transcranial Magnetic Stimulation in Neuropathic Pain

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of peripheral neuropathy
  • Neuropathic pain of constant severity for at least one month
  • Use of analgesics more than once a week for neuropathic pain
  • Pain intensity score of 30 millimeters or more on a 100 millimeter visual analog scale at inclusion
Not Eligible

You will not qualify if you...

  • Severe depression
  • Personality disorders or other psychiatric conditions affecting study participation
  • Cognitive deficits affecting study participation
  • Epilepsy
  • Presence of magnetic material within reach of the magnetic field
  • Pregnancy
  • Likelihood of becoming pregnant
  • Intracranial electrodes

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Jagiellonian University Medical College

Krakow, Poland, 31008

Actively Recruiting

Loading map...

Research Team

J

Jakub M Antczak, MD

CONTACT

G

Gabriela G Rusin, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here